Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-94.12%EBITDA Margin
VS
Market
Sector
Industry
History
$ 3.17Close
$ 2.08 - $ 6.95 52-Week Range
Ticker Information
Ticker
VVOSCompany Name
VIVOS THERAPEUTICS INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQVIVOS THERAPEUTICS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
VVOS - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -13.55M | -94.12% | $ 14.39M |
| 3/31/2025 | $ -10.63M | -72.63% | $ 14.63M |
| 12/31/2024 | $ -10.55M | -70.22% | $ 15.03M |
| 9/30/2024 | $ -11.98M | -82.18% | $ 14.58M |
| 6/30/2024 | $ -11.46M | -81.7% | $ 14.02M |
| 3/31/2024 | $ -15.05M | -112.63% | $ 13.36M |
| 12/31/2023 | $ -12.96M | -93.92% | $ 13.8M |
| 9/30/2023 | $ -15.15M | -104.5% | $ 14.5M |
| 6/30/2023 | $ -18.32M | -118.62% | $ 15.45M |
| 3/31/2023 | $ -19.41M | -119.57% | $ 16.24M |
Key Performance Insights, Last 5 Years
- VIVOS THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA % stands at -86.59%.
- Over the past 5 years, VIVOS THERAPEUTICS INC's average EBITDA % has been -104.39%.
- The median EBITDA % for VIVOS THERAPEUTICS INC during this period was -104.5%
- VIVOS THERAPEUTICS INC reached its highest EBITDA % over the past 5 years at -70.22%.
- The lowest EBITDA % recorded by VIVOS THERAPEUTICS INC in the same timeframe -146.31%
VIVOS THERAPEUTICS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for VIVOS THERAPEUTICS INC is calculated as follows: EBITDA [ $ -9.87M ] / Revenues [ $ 11.39M ]
(=) EBITDA % [ -86.59% ] VVOS - EBITDA Margin, Last 5 years
-146.31%
Minimum
Sep 30, 2022
-70.22%
Maximum
Dec 31, 2024
-104.39%
Average
-104.5%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -74.33% |
| max | 97.24% |
| average | 16.2% |
| median | 14.74% |
| std | 26.73% |